1-2 of 2
Ann Vo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis

Owhofasa O. Agbedia, Rishab Prakash, Jie Xu, Melody R. Becnel, Ranjit Nair, Raphael E Steiner, Lei Feng, Hun Ju Lee, Paolo Strati, Sairah Ahmed, Simrit Parmar, Yago Nieto, Chitra Hosing, Jason Westin, Loretta J. Nastoupil, Ann Vo, Felipe Samaniego, Nathan H. Fowler, Neeraj Saini, Issa F. Khouri, Jin S. Im, Luis Fayad, Preetesh Jain, Michael L. Wang, Roberto N. Miranda, Francisco Vega, Jeffrey Medeiros, Yasuhiro Oki, Christopher R. Flowers, Sattva S. Neelapu, Swaminathan P. Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2313–2315.
https://doi.org/10.1182/blood-2022-168983
Published: 2022
Journal Articles

A Phase II Study of Pembrolizumab in Combination with Romidepsin Demonstrates Durable Responses in Relapsed or Refractory T-Cell Lymphoma (TCL)

Swami P. Iyer, MD, Jie Xu, MD, Melody R. Becnel, MD, Ranjit Nair, MD, Raphael Steiner, MD, Lei Feng, MS, Hun Ju Lee, MD, Paolo Strati, MD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI, Yago Nieto, MD, Chitra Hosing, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Ann Vo, Felipe Samaniego, MD, Nathan H. Fowler, MD, Neeraj Saini, MD, Issa F. Khouri, MD, Jin S. Im, Preetesh Jain, MBBS,MDDM,PhD, Luis Fayad, Michael Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MDPhD, Christopher Flowers, MDMS, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-143252
Published: 2020